Stock Price Quote

NATCO PHARMA LTD.

NSE : NATCOPHARMBSE : 524816ISIN CODE : INE987B01026Industry : Pharmaceuticals & DrugsHouse : Natco
BSE877.20-2.3 (-0.26 %)
PREV CLOSE ( ) 879.50
OPEN PRICE ( ) 881.60
BID PRICE (QTY) 877.25 (24)
OFFER PRICE (QTY) 878.40 (1)
VOLUME 3711
TODAY'S LOW / HIGH ( )872.60 884.15
52 WK LOW / HIGH ( )771 1188.95
NSE878.80-1.15 (-0.13 %)
PREV CLOSE( ) 879.95
OPEN PRICE ( ) 884.35
BID PRICE (QTY) 878.05 (16)
OFFER PRICE (QTY) 878.80 (21)
VOLUME 124248
TODAY'S LOW / HIGH( ) 871.10 886.00
52 WK LOW / HIGH ( )771.5 1189
1D 1M 3M 1Y 3Y 5Y

STOCK SUMMARY

Incorporation Year : 19-09 1981
Management Info
V C Nannapaneni - Chairman V C Nannapaneni - Managing Director
Registered Office

Address Natco House,Road No 2,Banjara Hills,
Hyderabad,
Telangana-500003

Phone 040-23547532

Email investors@natcopharma.co.in

Website www.natcopharma.co.in

Registrars Details
Venture Capital & Corporate Investments Ltd
12-10-167,,MIG- 167,,Bharat Nagar Colony,Hyderabad
Listing : BSE, NSE, MCX

NEWS

03Sep Natco Pharma informs about newspaper a
Pursuant to Regulations 30 and 47 of the SEBI (Listing Obligations and D..
02Sep Natco Pharma’s arm launches NAT-LENALI
Natco Pharma’s subsidiary -- Natco Pharma (Canada) Inc. has launched NAT..
02Sep Natco Pharma soars as its arm launches
Natco Pharma is currently trading at Rs. 975.70, up by 35.10 points or 3..
02Sep Natco Pharma informs about press release
Natco Pharma has informed that it enclosed a press release on 2nd Septem..
20Aug Natco Pharma informs about disclosure
Natco Pharma has informed that it enclosed the disclosure titled ‘Legal..

Financials

in Millions
QTR Jun 21 ANNUAL 21
Net Profit7523095
Gross Profit 910 3922
Operating Profit 12595187
Net Sales 393816535

ROLLING FORWARD P/E (EOD)

EVENT CALENDAR

peer group

Astrazeneca Pharma I (BSE)
peergroup  3121.00 (1.20%)
M.Cap ( in Cr)7790.75
Kwality Pharma (BSE)
peergroup  723.10 (4.99%)
M.Cap ( in Cr)750.30
JB Chem & Pharma (BSE)
peergroup  1862.40 (1.43%)
M.Cap ( in Cr)14486.92
Wockhardt (BSE)
peergroup  446.55 (5.00%)
M.Cap ( in Cr)4908.65
Eris Lifesciences (BSE)
peergroup  751.60 (2.02%)
M.Cap ( in Cr)10136.74

Shareholding Pattern

MUTUAL FUNDS/UTI 9%
PROMOTERS 48.87%
NON-INSTITUTION 21.19%
FI/BANKS/INSURANCE 0.16%
GOVERNMENT 0%
FII 0%

About Natco Pharma Ltd.

Natco Pharma Ltd. was incorporated in the year 1981. Its today's share price is 877.2. Its current market capitalisation stands at Rs 16042.99 Cr. In the latest quarter, company has reported Gross Sales of Rs. 16854 Cr and Total Income of Rs.17546 Cr. The company's management includes M Adinarayana, Sridhar Sankararaman, D Linga Rao, MUR Naidu, PSRK Prasad, Leela Digumarti, DG Prasad, Rajeev Nannapaneni, TV Rao, G S Murthy, V C Nannapaneni, V C Nannapaneni.

It is listed on the BSE with a BSE Code of 524816 , NSE with an NSE Symbol of NATCOPHARM and ISIN of INE987B01026. It's Registered office is at Natco House,Road No 2,Banjara HillsHyderabad-500003, Telangana. Their Registrars are ACC Ltd. It's auditors are Brahmayya & Co, BSR & Associates LLP, Walker Chandiok & Co LLP, Walker, Chandiok & Co, Walker, Chandiok & Co LLP

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)